Company Filing History:
2 out of 923 
1 out of 7 
1 out of 6 Years Active: 2017-2019
Title: The Innovations of Greg Watt
Introduction
Greg Watt is a notable inventor based in Bristol, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of antiviral compounds. With a total of 2 patents, his work focuses on addressing critical health issues, such as viral infections.
Latest Patents
One of Greg Watt's latest patents is titled "Macrocyclic inhibitors of flaviviridae viruses." This patent provides compounds of Formula I and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods described are particularly useful for the treatment of virus infections, especially hepatitis C infections.
Career Highlights
Throughout his career, Greg has worked with prominent companies in the pharmaceutical industry. Notable among these are Gilead Sciences, Inc. and Selcia Limited. His experience in these organizations has contributed to his expertise in developing innovative solutions for viral infections.
Collaborations
Greg has collaborated with several professionals in his field, including Caroline Aciro and Jean Yves Chiva. These collaborations have further enhanced his research and development efforts.
Conclusion
In summary, Greg Watt is a distinguished inventor whose work in antiviral compounds has the potential to make a significant impact on public health. His patents and collaborations reflect his commitment to innovation in the pharmaceutical industry.